Fayad Al-Haimus: Is Giving TXA Within ‘3 Hours’ Really Enough in Major Trauma?
Fayad Al-Haimus, Adult Thrombosis Fellow at McMaster University, shared a post on LinkedIn about a recent article by Adnan Ali et al. published in Annals of Emergency Medicine:
“Important study to highlight:
Is giving TXA within ‘3 hours’ really enough?
A new Annals of Emergency Medicine analysis from the PATCH-Trauma trial challenges how we think about tranexamic acid (TXA) in major trauma.
Study context:
PATCH-Trauma enrolled >1,300 patients with major trauma across 15 EMS services and 21 trauma centres in Australia, New Zealand, and Germany. The new study was exploratory, post-hoc analysis of the trial.
Key finding:
TXA was associated with a significant reduction in 28-day mortality when given within ~90 minutes of injury.
<90 min: 17% vs 25% mortality (TXA vs placebo). Adjusted RR 0.64 (95% CI 0.50–0.82)
≥90 min: no mortality benefit (adjusted RR 1.04)
This is notable because:
• PATCH used precise prehospital timestamps, unlike CRASH-2
• TXA was given early, prehospital
Takeaway:
As trauma care becomes more precision-focused, this study adds to the growing signal that early hemostatic decisions matter as much as what we give.”
Title: Tranexamic Acid Timing and Mortality Impact After Trauma
Authors: Adnan Ali, Russell L. Gruen, Stephen A. Bernard, Brian Burns, Andrew B. Forbes, Dashiell C. Gantner, Colin J. McArthur, Marc Maegele, Biswadev Mitra
Read the Full Article on Annals of Emergency Medicine

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines